The University of Hong Kong is the lead sponsor of 28 current clinical trials in our China register. 18 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Silver diamine fluoride, Carboplatin and Dulaglutide. The most-studied condition is Subfertility.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
The "Quit-for-Kids" Project: to Increase Abstinence and Protect Children From Tobacco Smoke Exposure
NCT06127589 · Smoking Cessation, Second Hand Tobacco Smoke
|
Not applicable | Recruiting | 2024-02 | China |
|
The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy
NCT06740071 · ClinicalTrials.gov ↗ · Prostate Cancer (Post Prostatectomy)
|
Not applicable | Recruiting | 2023-05 | China |
|
Emergency PWAS in Respiratory Infectious Disease
NCT05336851 · ClinicalTrials.gov ↗ · Viral Infections, Bacterial Infections, Fungal Infections
|
Observational | Recruiting | 2023-04 | China |
|
Translational Immunodiagnostics in Stroke (TrImS)
NCT05300997 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke, Haemorrhagic Stroke, Transient Ischemic Attacks
|
Observational | Recruiting | 2022-05 | China |
|
Comparing FET Guided by ERA Vs Standard Timing in Patients with Recurrent Implantation Failure
NCT06762626 · ClinicalTrials.gov ↗ · Recurrent Implantation Failure, Infertility
|
Not applicable | Recruiting | 2025-02 | China |
|
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07023484 · ClinicalTrials.gov ↗ · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Drugs: Carboplatin, Paclitaxel |
Phase 2 | Recruiting | 2025-05 | China |
|
Older People's Preventive Care Utilization
NCT05691790 · ClinicalTrials.gov ↗ · Health Communication
|
Not applicable | Recruiting | 2024-10 | China |
|
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
NCT04064840 · ClinicalTrials.gov ↗ · Subfertility
|
Phase 3 | Recruiting | 2019-09 | China |
|
Testicular Function and Semen Quality in Male Childhood and Adolescent Cancer Survivors
NCT06587477 · ClinicalTrials.gov ↗ · Cancer, Treatment-Related, Late Effect, Semen Analysis
|
Observational | Recruiting | 2023-01 | China |
|
A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse
NCT07616999 · ClinicalTrials.gov ↗ · Schizophrenia
|
Observational | Recruiting | 2026-05 | China |
|
Nurse-supported Mobile App for Self-help CBT-I in Informal Cancer Caregivers
NCT07089797 · ClinicalTrials.gov ↗ · Insomnia Chronic, Cancer Caregivers
|
Not applicable | Recruiting | 2025-08 | China |
|
Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
NCT03859921 · ClinicalTrials.gov ↗ · Subfertility
|
Phase 3 | Recruiting | 2021-07 | China |
|
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
NCT06324461 · ClinicalTrials.gov ↗ · Myocardial Injury
Drug: Dulaglutide |
Phase 4 | Recruiting | 2024-03 | China |
|
Role of Exercise in PRISm and Subsequent Development of COPD
NCT07387432 · ClinicalTrials.gov ↗ · Preserved Ratio Impaired Spirometry (PRISM)
|
Not applicable | Recruiting | 2025-07 | China |
|
Health Chat for Empowerment-based Lifestyle Planning for Cardiometabolic Multimorbidity
NCT07158697 · ClinicalTrials.gov ↗ · Cardiometabolic Diseases, Multimorbidity
|
Not applicable | Recruiting | 2025-09 | China |
|
Dyadic Sport Stacking Program for Mild Dementia and Their Family Caregivers
NCT06597981 · ClinicalTrials.gov ↗ · Dementia, Family Caregivers, Dyadic Intervention
|
Not applicable | Recruiting | 2024-09 | China |
|
Acupressure for Cough in Lung Cancer Survivors
NCT07315672 · ClinicalTrials.gov ↗ · Lung Cancer (Diagnosis), Acupressure, Coughing
|
Not applicable | Recruiting | 2026-03 | China |
|
SOCIAL_HF: Improving Social Frailty Through Interactive Learning
NCT07234565 · ClinicalTrials.gov ↗ · Heart Failure
|
Not applicable | Recruiting | 2025-09 | China |
|
Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China
NCT07718867 · ClinicalTrials.gov ↗ · Type 2 Diabetes, Pre-diabetes
|
Not applicable | Not yet open | 2026-07 | China |
|
rTMS for Cerebellar Ataxia in Children
NCT07211490 · ClinicalTrials.gov ↗ · Cerebellar Ataxia
|
Not applicable | Not yet open | 2025-10 | China |
|
Pleurodesis in Small-bore Chest Tube
NCT07208409 · ClinicalTrials.gov ↗ · Pleural Effusion, Malignant
|
Not applicable | Not yet open | 2026-02 | China |
|
Camouflaged WeChat-based Intervention for Abused Women
NCT07405528 · ClinicalTrials.gov ↗ · Domestic Violence, Mental Health Wellness 1
|
Not applicable | Not yet open | 2026-02 | China |
|
Testing the Performance of Smartphones and Their Accessories in Detecting Irregularly Irregular Heart Rhythm
NCT07154303 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)
|
Observational | By invitation | 2025-08 | China |
|
WeChat-Based Digital Therapy to Improve Fluid Intake in Kidney Stone Patients: Study Protocol
NCT06990672 · ClinicalTrials.gov ↗ · Urinary Calculi, Postoperative Care, Chronic Disease Prevention
|
Not applicable | By invitation | 2025-03 | China |
|
Arresting Early Childhood Caries With a Silver Diamine Fluoride Gel
NCT06241261 · ClinicalTrials.gov ↗ · Early Childhood Caries
Drug: Silver diamine fluoride |
Phase 2 | Active, closed | 2024-01 | China |
|
Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong
NCT02957890 · ClinicalTrials.gov ↗ · Influenza, Human
|
Phase 4 | Active, closed | 2016-11 | China |
|
Preventing Early Childhood Caries With a Silver Diamine Fluoride Gel
NCT07455604 · ClinicalTrials.gov ↗ · Early Childhood Caries (ECC)
Drug: Silver diamine fluoride |
Phase 2 | Active, closed | 2026-01 | China |
|
Smartphone App for Non-alcoholic Fatty Liver Disease
NCT05180760 · ClinicalTrials.gov ↗ · Non-Alcoholic Fatty Liver Disease
|
Not applicable | Active, closed | 2023-07 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 28 | 18 |
A trial with sites in more than one country appears in each of those registers.
The University of Hong Kong is the lead sponsor of 28 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 18 of its 28 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Its current trials name 4 drugs and biologicals as interventions. The most frequent are Silver diamine fluoride (2), Carboplatin (1), Dulaglutide (1) and Paclitaxel (1). The number in brackets is how many of its trials name each drug.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.